The drugmaker said the affected products may contain a higher concentration of ibuprofen than indicated on the label.
Tris Pharma first announced the voluntary recall in December, saying it involved products sold under Walmart, CVS Pharmacy and Family Dollar brands. The expanded recall affects more products made for CVS and Walmart.
Tris Pharma said it has not received any reports of adverse events linked to the recalled products.
For more information on the recall, click here.
More articles on pharmacy:
Prescription drug price transparency and its visible impact on medication adherence
Key thoughts on controlling pharmacy spend for hospitals
CVS, Walgreens piloting dental services: 3 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.